International life sciences regulations: How CROs, CMOs, and CDMOs are primed for advantage Vishal Goel Oct 16, 2024 Vishal Goel, MD, Rx Propellant elaborates how Indian CROs, CMOs, and CDMOs can enhance their competitive edge by investing in…
Passing of Biosecure Act a positive development Jonathan Hunt Sep 15, 2024 Jonathan Hunt MD and CEO, Syngene International analyses that though the change in the Biosecure Act around the timeline of…
India currently contributes three-to-five per cent share of the global biotechnology sector Akanki Sharma Oct 11, 2021 The outsourcing market size for CDMOs in India is roughly at Rs 20,000 crores and it is expected to grow to about Rs 40,000 crores…
